Schindel Yair Chaim 13D and 13G filings for Viracta Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-01-10 5:21 pm Unchanged | 2022-06-08 | 13D | Viracta Therapeutics, Inc. VIRX | Schindel Yair Chaim | 7,392,237 19.350% | 0 (Unchanged) | Filing |
| 2023-01-10 4:35 pm Unchanged | 2022-06-08 | 13D | Viracta Therapeutics, Inc. VIRX | Schindel Yair Chaim | 7,392,237 19.350% | 0 (Unchanged) | Filing |
| 2021-03-02 06:14 am Purchase | 2021-02-24 | 13D | Viracta Therapeutics, Inc. VIRX | Schindel Yair Chaim | 7,392,237 19.980% | 7,392,237 (New Position) | Filing |
| 2021-03-01 06:06 am Purchase | 2021-02-24 | 13D | Viracta Therapeutics, Inc. VIRX | Schindel Yair Chaim | 7,392,237 19.980% | 7,392,237 (New Position) | Filing |